Prelude Therapeutics
PRLD
PRLD
54 hedge funds and large institutions have $180M invested in Prelude Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Holders
54
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.98M | |
| 2 | +$495K | |
| 3 | +$483K | |
| 4 |
Morgan Stanley
New York
|
+$295K |
| 5 |
Jane Street
New York
|
+$272K |
Top Sellers
| 1 | -$1.09M | |
| 2 | -$739K | |
| 3 | -$495K | |
| 4 |
Barclays
London,
United Kingdom
|
-$460K |
| 5 |
CANY
Caxton Associates (New York)
New York
|
-$395K |